Back to Transactions
Industrial Engineering & Manufacturing | Healthcare
2016

Perusa has sold gb Implant Technology to AC Pio GmbH

Client: Perusa GmbH

Client Location: United Kingdom

Target: gb Implantat-Technologie GmbH

Target Location: Germany

Buyer: AC Pio GmbH

Buyer Location: Germany

Target Description: gbIT is a specialized medical custom manufacturer with a proprietary in-house CoCr foundry offering the full production workflow based on the own branded cobalt-chrome medical alloys.

Perusa GbImplant AC Pio 2016

Related
Perspectives

Connect with a Senior Team Member

Meet our Senior Team in Healthcare

Sound advice coupled with deep sector knowledge and international reach is how I add value and lead to successful outcomes for my clients.

Gunnar Brundin

Managing Director

Stockholm

Fatheazam Shahab
The healthcare market is ever-changing and increasingly complex and always puts one in touch with exceptional people of many talents.

Shahab Fatheazam

Vice Chairman | Healthcare

Chicago

Barry Freeman
I am a fierce, tireless advocate for my clients in securing world-class outcomes on their transactions.

Barry Freeman

Managing Director

Chicago

Honesty and integrity are very important to me. I have a genuine interest in learning about clients and their businesses, as well as pushing myself to continuously evolve in my role as a valued advisor.

Cynthya Goulet

Managing Director

Chicago

It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.

Matthew Lee

Managing Director

London

Dirk Loeffler
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.

Dirk-Oliver Löffler

Managing Director | European Co-head Healthcare

Frankfurt

Gaurav Marathe
The opportunity to advise accomplished business professionals and be part of their growth story and value creation is what keeps me inspired to work in this industry

Gaurav Marathe

Managing Director | CEO India

Mumbai

Roderick O'Niell
My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.

Roderick O’Neill

Managing Director

New York

François Rispoli
I strive to be a trusted advisor to my clients, adding value throughout their journey, and helping them to reach successful outcomes.

François Rispoli

Managing Director

Paris

Derek Ritchea
I enjoy partnering with disruptive healthcare technology businesses and executives, providing support to achieve their long-term growth objectives in their pursuit to revolutionize the industry.

Derek Ritchea

Managing Director

New York

Siano Mike 616x616
It is exciting to be a part of the incredible transformation underway in the healthcare sector and I work passionately to help clients achieve exceptional results.

Michael Siano

Managing Director

New York

James West
I strive to build long-term relationships with key individuals in my sectors of focus in order to provide the best advisory services for my clients.

James West

Managing Director

London

View All

View More Transactions in Healthcare

nspm has been sold to Cactus Life Sciences, a subsidiary of Cactus Global

Healthcare

Lincoln International advised ECONA on receiving strategic advice on potential options for nexmed

Healthcare

Lincoln International advised Gilde Healthcare on its agreement to sell RAD-x to Swiss Life Asset Managers and Vesper Infrastructure Partners

Healthcare

Lincoln International advised Bridgepoint Growth on the acquisition of Identicare from Animalcare Group

Healthcare

Lincoln International advised Varsity Healthcare Partners on the sale of Angels of Care Pediatric Home Health to Nautic Partners

Healthcare

Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings

Healthcare

Lincoln International advised Talisman Capital Partners on the sale of ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners

Healthcare

Lincoln International advised Mars on the sale of Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners

Healthcare
View All

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.